Biotechnology Assets SA
MAD:BST

Watchlist Manager
Biotechnology Assets SA Logo
Biotechnology Assets SA
MAD:BST
Watchlist
Price: 0.39 EUR 7.14% Market Closed
Market Cap: 26.8m EUR

Intrinsic Value

The intrinsic value of one BST stock under the Base Case scenario is 0.23 EUR. Compared to the current market price of 0.39 EUR, Biotechnology Assets SA is Overvalued by 41%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BST Intrinsic Value
0.23 EUR
Overvaluation 41%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Biotechnology Assets SA

What is Valuation History?
Compare BST to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BST?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Biotechnology Assets SA
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biotechnology Assets SA

Current Assets 3.7m
Cash & Short-Term Investments 261.8k
Receivables 3.4m
Non-Current Assets 11.1m
Long-Term Investments 448.3k
PP&E 2.3m
Intangibles 5.6m
Other Non-Current Assets 2.7m
Efficiency

Free Cash Flow Analysis
Biotechnology Assets SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Biotechnology Assets SA

Revenue
2.5m EUR
Cost of Revenue
-600.5k EUR
Gross Profit
1.9m EUR
Operating Expenses
-3.9m EUR
Operating Income
-2m EUR
Other Expenses
-914.7k EUR
Net Income
-2.9m EUR
Fundamental Scores

BST Profitability Score
Profitability Due Diligence

Biotechnology Assets SA's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Gross Margin is Increasing
29/100
Profitability
Score

Biotechnology Assets SA's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

BST Solvency Score
Solvency Due Diligence

Biotechnology Assets SA's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
33/100
Solvency
Score

Biotechnology Assets SA's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BST Price Targets Summary
Biotechnology Assets SA

There are no price targets for BST.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BST is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one BST stock?

The intrinsic value of one BST stock under the Base Case scenario is 0.23 EUR.

Is BST stock undervalued or overvalued?

Compared to the current market price of 0.39 EUR, Biotechnology Assets SA is Overvalued by 41%.

Back to Top